We distinguished the funding to AECL to produce medical isotopes out of the NRU reactor from the funding provided to companies that are looking at alternative ways to produce medical isotopes. From the first item of the money to AECL to produce medical isotopes that would be part of the overall funding, there are commercial contracts between AECL and the supply chain. I cannot go into the exact details, but the funding provided to AECL would cover the operations required to continue the production of medical isotopes until October 2016, which is the date at which the NRU reactor would cease to produce medical isotopes.
As for your second question regarding the alternative ways to produce medical isotopes at places like TRIUMF, the University of Alberta, or the Prairie Enterprise, Natural Resources Canada has a program in place to fund these three projects and they are developing technologies to produce medical isotopes that would not require a reactor. At TRIUMF and the University of Alberta they're using cyclotrons, for example, to produce medical isotopes. The programs we have in place at NRCan have been supporting development of these technologies. Since 2010, $60 million has been spent to support these Canadian technologies.